placeNew Zealand
Contact Us
Minimally Invasive Therapies / Products / Vessel Sealing / LigaSure™ Exact Dissector

Overview

Introducing the LigaSure™ exact dissector

Built on our LigaSure™ technology, our newest surgical advancement offers faster cooling times2 with improved access and more precise dissection.1,†

Features

A Cooler Option for Fine Dissection2

Our new LigaSure™ exact dissector makes cutting and sealing simple.1,§

Low Temperature Profile

The LigaSure™ exact dissector is designed to:

  • Cool down fast for secure and atraumatic tissue grasping1,Ω
  • Stay cool over multiple activations2


Precise Performance

The fine, curved jaw of the LigaSure™ exact dissector:

  • Allows for precision around critical structures‡
  • Enhances the ability to work in tight spaces1,‡
  • Maximises the line of sight1,§

Its jaw also applies equal force on opposing tissue planes for effective blunt dissection.

Balanced Handling

Engineered for fine dissection, the LigaSure™ exact dissector offers:

  • A working length that’s designed to provide precise control1,††
  • A cutting trigger that’s aligned with the handle, eliminating interference with the wound edge1,††


Improved Efficiency

The fast cooling times of the LigaSure™ exact dissector mean:

  • Fewer instrument exchanges‡‡
  • More efficient procedures in the OR§§

All delivered with the speed and reliable performance of LigaSure™ vessel sealing technology.

/content/dam/covidien/library/global/en/product/vessel-sealing/ligasure-exact-dissector-f.jpg
Order Information
Order Code Description Unit of Measure Quantity
LF2019 LigaSure™ Exact Dissector Case 6
Specifications
Jaw Tip Curvature 40 degrees
Jaw Length 21.6 mm
Cut Length 19.8 mm
Seal Length 20.6 mm
Jaw Width at Tip 2 mm
Jaw Width at Base 4 mm
Instrument Length 21 cm
Generator Compatibility Valleylab™ FT10 energy platform and Valleylab™ LS10 energy platform (where available)

Order Information

  • †Compared to the LigaSure™ small jaw device (16 out of 16 surgeons surveyed agreed) and the Harmonic Focus™*+ device (11 out of 12 surgeons agreed).

  • ‡21 out of 22 surgeons surveyed agreed.

  • §23 out of 23 surgeons surveyed agreed.

  • Ω19 out of 21 surgeons surveyed agreed.

  • ††22 out of 23 surgeons surveyed agreed.

  • ‡‡13 out of 14 surgeons agreed.

  • §§11 out of 12 surgeons agreed.

About Medtronic
Minimally Invasive Therapies
Contact Us
Country Office

Level 3 - Building 5

Central Corporate Centre

666 Great South Road

Penrose, Auckland

New Zealand

©2024 Medtronic